Loading clinical trials...
Loading clinical trials...
This is A two-arm, open-label, single-sequence, multiple oral dosings, crossover study to evaluate the safety and the pharmacokinetic interaction of DWC202313 and DWC202314 in healthy adult volunteers...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Daewoong Pharmaceutical Co. LTD.
NCT07282379 · Frailty, Emergency Department Visit, and more
NCT06917508 · RSV Infection, Drug Drug Interaction
NCT05942365 · Drug Drug Interaction, Warfarin, and more
NCT05574374 · Drug Drug Interaction
NCT05181007 · Drug Drug Interaction
H Plus YANGJI Hospital
Seoul
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions